Liguo Hao
Qiqihar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Proton Sponge-Enabled Dual-Driven Nanomotors for MRI-Guided Tumor-Penetrating Synergistic Therapy of Pancreatic Cancer.
Journal: Advanced healthcare materials
Published: May 26, 2026
Basic research on gadolinium-based drug-loaded nanoprobes coated with platelet membranes for the diagnosis and treatment of atherosclerosis.
Journal: Colloids and surfaces. B, Biointerfaces
Published: December 16, 2025
Study on the inhibition of thyroid undifferentiated carcinoma metastasis by nanoparticles loaded with EZH2 inhibitor.
Journal: Translational cancer research
Published: November 05, 2025
The upregulated RNA circ_0060055 regulates the proliferation, invasion and apoptosis of pancreatic cancer cells through spongy miR-1298-5p.
Journal: Medical oncology (Northwood, London, England)
Published: October 26, 2025
CTHRC1 promotes hepatocellular carcinoma proliferation, migration and invasion by regulating VEGF expression and validation of MRI images.
Journal: Technology and health care : official journal of the European Society for Engineering and Medicine
Published: July 16, 2025
Multimodal Imaging-Guided Tumor Microenvironment-Responsive Nanoplatform for Synergistic Therapy of Pancreatic Cancer.
Journal: International journal of nanomedicine
Published: May 25, 2025
pH/GSH Dual-Responsive Janus-Type Au@H-MP@DOX MR Molecular Imaging Nanomotor for Combined Photothermal/Chemotherapeutic Treatment of Pancreatic Cancer.
Journal: Molecular pharmaceutics
Published: May 21, 2025
Correction: Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer.
Journal: Drug delivery and translational research
Published: November 13, 2024
cRGD-based MRI imaging-enhanced nanoplatform helps DOX target pancreatic cancer.
Journal: Scientific reports
Published: November 11, 2024
Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer.
Journal: Drug delivery and translational research
Published: October 10, 2024
Ultrasound/magnetic resonance bimodal imaging-guided CD20-targeted multifunctional nanoplatform for photothermal/chemo synergistic therapy of B-cell lymphoma.
Journal: Journal of pharmaceutical sciences
Published: September 05, 2024
Dextran Sulfate-Modified and pH-Responsive Nanoprobes for Magnetic Resonance/Fluorescence Dual-Modality Imaging of Vulnerable Plaques.
Journal: Journal of biomedical materials research. Part A
Published: August 30, 2024
Last Updated: 09/26/2026